Should I buy Certara, Inc. (CERT) stock or is it too late?

Certara, Inc. · Health Care · price $10

See the full Certara, Inc. (CERT) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: UBS — 59% of its targets hit on this sector (76 calls tested). It aims for $10 (+4.2 %), call made on October 1, 2026, maturing on October 1, 2027 (13 d ago).

The 1 reliable analyst $10+4.2 %

The 7 other firms $9-6.2 %

How to read it: the 1 reliable firms are not filtered by optimism — 1 aim above the price, 0 below, hence their $10 median. “The 7 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Certara, Inc.

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Barclays	22 %	-17.2 %	9	$9 -6%
Keybanc	0 %	-39.6 %	5	$8 -17%
Credit Suisse	0 %	-14.9 %	5	—

In short — Should you invest in Certara, Inc.? Is it too late, still worth it? Analysts are split (25% buy, median target $9, i.e. -6%), and the most reliable on CERT targets even higher. But it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

The most reliable firm on CERT, UBS (50% hit rate, 2 scored calls), targets $10 (call made on September 30, 2026, maturing on September 30, 2027) (+4%) in its most recent call.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 8 ratings, 6 are neutral.
Limited upside: the median target is only -6% from the current price.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
No dividend: your return depends only on price appreciation.

The analyst consensus on CERT

Median target $9 (-6%) · 8 ratings · Hold consensus

Strong Buy00%

Buy225%

Hold675%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Certara, Inc. now?

We won't decide for you. The facts: 25% of analysts rate it a buy, median target $9 (-6%), and UBS (most reliable on CERT, 50%) targets $10. Weigh that against valuation. This is not personalized advice.

Is it too late to invest in Certara, Inc.?

The stated upside is small: the median target ($9) sits just -6% from the price ($10) (most reliable on CERT: UBS, 50%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Certara, Inc. still worth investing in?

It depends on the gap between the price ($10) and its estimated value: analysts target $9 on median (-6%), with 25% buys (most reliable on CERT: UBS, 50%). Cross-check with their real reliability on CERT and the cautions above. Information, not advice.

What's the main risk in buying CERT?

The consensus is not unanimous: of 8 ratings, 6 are neutral.

→ Go deeper: the full Certara, Inc. profile (consensus, analyst reliability, price target, performance).